Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.090
+0.080 (3.98%)
At close: Jul 21, 2025, 4:00 PM
2.090
0.00 (0.00%)
Pre-market: Jul 22, 2025, 8:00 AM EDT
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $800.14 million as of July 22, 2025. Its market cap has decreased by -9.72% in one year.
Market Cap
800.14M
Enterprise Value
-27.43M
1-Year Change
-9.72%
Ranking
Category
Stock Price
$2.09
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $800.14M, a decrease of -29.70%. That is a compound annual growth rate of -4.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2025 | 805.50M | 4.31% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.79B |
| Johnson & Johnson | 393.87B |
| AbbVie | 334.31B |
| Novo Nordisk | 287.38B |
| UnitedHealth Group | 256.40B |
| Novartis AG | 223.49B |
| Abbott Laboratories | 215.17B |
| AstraZeneca | 214.61B |